You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dopamine transporter binding

Showing 1 - 25 of 2,715
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-motor Symptoms and Brain Dopamine Transporter Binding

Active, not recruiting
  • Parkinson Disease
  • Parkinsonism
  • DAT SPECT imaging
  • (no location specified)
Oct 12, 2021

Idiopathic Parkinson's Progression and Dopamine Transporter

Completed
  • Parkinson Disease
  • Ioflupane I 123
  • Lexington, Kentucky
    University of Kentucky Department of Neurology
Nov 16, 2022

Obesity Trial in Busan (Glucose injection/Normal saline injection)

Completed
  • Obesity
  • Glucose injection/Normal saline injection
  • Busan, Korea, Republic of
    Pusan National University Hospital
Apr 19, 2022

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • PET scans
  • (no location specified)
Nov 9, 2022

Parkinson Disease Trial in New Haven (B-CIT and SPECT imaging)

Completed
  • Parkinson Disease
  • B-CIT and SPECT imaging
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Jul 1, 2022

Neurotoxicity in Gastrointestinal Cancer Patients Receiving

Recruiting
  • Gastrointestinal Cancer
  • Folfox Protocol
  • Cairo, Abassia, Egypt
    Ain shams university
Aug 8, 2022

Parkinson Disease, Movement Disorders Trial (Altropane (123I) Injection)

Not yet recruiting
  • Parkinson Disease
  • Movement Disorders
  • Altropane (123I) Injection
  • (no location specified)
Nov 23, 2022

Multiple System Atrophy Trial in Irvine, Columbus (AAV2-GDNF gene therapy, Sham (Placebo) Surgery)

Recruiting
  • Multiple System Atrophy
  • AAV2-GDNF gene therapy
  • Sham (Placebo) Surgery
  • Irvine, California
  • +1 more
Jan 18, 2023

Depression Trial in Philadelphia (drug, behavioral, procedure)

Completed
Has Results
  • Depression
  • Philadelphia, Pennsylvania
    Depression Research Unit - University of Pennsylvania
Apr 3, 2020

Pathophysiology of Gilles de la Tourette Syndrome. Part 1:

Not yet recruiting
  • Gilles de la Tourette Syndrome
  • Tourette Syndrome
  • PET/MR scanner
  • Leipzig, Germany
    Max Planck Institute for Human Cognitive and Brain Sciences
Feb 11, 2022

Parkinson Disease Trial in Lund, Cambridge (STEM-PD)

Recruiting
  • Parkinson Disease
  • STEM-PD
  • Lund, Sweden
  • +1 more
Dec 7, 2022

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Recruiting
  • Long COVID
  • +2 more
  • [11C]DTBZ PET scan
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Oct 15, 2023

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

Withdrawn
  • Schizophrenia
  • NPA radiotracer
  • +2 more
  • New York, New York
    NYU Langone Health
May 27, 2020

ADHDs Trial in Vancouver (Psychostimulants)

Active, not recruiting
  • Attention Deficit Hyperactivity Disorders
  • Vancouver, British Columbia, Canada
    Developmental Cognitive Neuroscience Lab, Department of Psychiat
May 16, 2022

Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T

Recruiting
  • Gilles de la Tourette Syndrome
  • Tourette Syndrome
  • MRI scanner (7 Tesla)
  • Leipzig, Germany
    Max Planck Institute for Human Cognitive and Brain Sciences
Feb 10, 2022

Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA) Trial in China (DaTSCAN™ Ioflupane (123I) Injection)

Completed
  • Parkinsonian Syndrome
  • +3 more
  • DaTSCAN™ Ioflupane (123I) Injection
  • Beijing, Chaoyang District, China
  • +9 more
Jun 20, 2022

Parkinson Disease Trial in Orléans (Additional acquisition)

Recruiting
  • Parkinson Disease
  • Additional acquisition
  • Orléans, France
    CHR d'Orleans
Dec 27, 2022

DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

Not yet recruiting
  • Parkinson Disease
  • scintigraphy DaTSCAN
  • Vandœuvre-lès-Nancy, France
    CHRU Nancy
Jan 5, 2023

Narcolepsy With Cataplexy, Healthy Controls Trial in Toronto (Xyrem)

Completed
Has Results
  • Narcolepsy With Cataplexy
  • Healthy Controls
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health (CAMH)
Feb 26, 2021

REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease Trial in Los Angeles (Carvedilol)

Enrolling by invitation
  • REM Sleep Behavior Disorder
  • +2 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Jul 26, 2021

Parkinson's Disease Trial in Las Vegas (UCB0599)

Enrolling by invitation
  • Parkinson's Disease
  • Las Vegas, Nevada
    Pd0055 50397
Sep 13, 2022

Functional Relevance of Dopamine Receptors in Healthy Controls

Recruiting
  • Schizoaffective Disorder
  • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Adjustment Disorder With Work Inhibition Trial in Odense (PET/MR scans)

    Enrolling by invitation
    • Adjustment Disorder With Work Inhibition
    • PET/MR scans
    • Odense, Denmark
      Odense University Hospital
    Sep 22, 2022